The growing interest in effective weight management has resulted in considerable investigation into novel treatments. Recently , Retatrutide, a combined -action hormone and glucagon-like peptide-1 (GLP-1) receptor activator , has exhibited positive results in medical trials, indicating potential for considerable weight decrease. As a result , many